Corpus ID: 23612699

A randomized, controlled trial of treatment of alcoholic hepatitis with parenteral nutrition and oxandrolone. I. Short-term effects on liver function.

  title={A randomized, controlled trial of treatment of alcoholic hepatitis with parenteral nutrition and oxandrolone. I. Short-term effects on liver function.},
  author={Herbert L. Bonkovsky and David A. Fiellin and G. S. Smith and D P Slaker and Dawn M. Simon and John T. Galambos},
  journal={The American journal of gastroenterology},
  volume={86 9},
The present studies were designed to provide careful measures of effects of oxandrolone, an anabolic steroid, intravenous nutritional supplementation, and the combination of these two treatments on liver functions, metabolic balances, nitrogen metabolism, and nutritional status in patients with moderate to severe alcoholic hepatitis. Of 43 patients originally recruited, 39 (19 men, 20 women) with typical clinical and laboratory features of alcoholic hepatitis (11 Child's-Pugh class B; 28 class… Expand
Nutritional therapy in alcoholic liver disease
Chronic alcohol consumption may lead to primary and secondary malnutrition. In particular, protein energy malnutrition not only aggravates alcoholic liver disease but also correlates with impairedExpand
Energy and protein requirements of patients with chronic liver disease.
This review attempts to provide a basis for understanding the aetiology of malnutrition in patients with cirrhosis, and defining the requirement for energy and protein in clinically stable malnourished patients with Cirrhosis and discussing the clinical significance of fulfilling these requirements. Expand
Adjunctive therapies in nutritional support.
It is likely that current methods of enteral and parenteral nutrition support will evolve in response to the results of these research studies, as well as new therapeutic approaches to improve the metabolic and clinical efficacy of nutritional therapy. Expand
Nutritional support for liver disease.
The primary outcomes of this review were mortality, hepatic morbidity, quality of life, and adverse events. Expand
Hepatology – Guidelines on Parenteral Nutrition, Chapter 16
Parenteral nutrition is indicated in alcoholic steatohepatitis and in cirrhotic patients with moderate or severe malnutrition and in acute liver failure artificial nutrition should be considered irrespective of the nutritional state and should be commenced when oral nutrition cannot be restarted within 5 to 7 days. Expand
Diagnosis and Treatment of Alcoholic Hepatitis: A Systematic Review.
A systematic review of clinical characteristics and genomics associated with the risk of alcoholic hepatitis found an unmet need for noninvasive biomarkers for the diagnosis, and predicting prognosis and response to therapy. Expand
The Anabolic Androgenic Steroid Oxandrolone in the Treatment of Wasting and Catabolic Disorders
Strong evidence of its clinical efficacy is provided and optimal risk: benefit ratios for oxandrolone and other agents in its class will need to be refined before widespread clinical acceptance of AASs as a therapeutic option in sarcopenia and other chronic wasting conditions. Expand
Severe acute alcoholic hepatitis: an audit of medical treatment.
It is found that mortality was concentrated in a subgroup of patients with a discriminant function value >32 and contra-indications to steroids and experimental treatments need to be targeted at this group to improve the overall prognosis of acute alcoholic hepatitis. Expand
Do data support nutrition support? Part I: intravenous nutrition.
  • R. Koretz
  • Medicine
  • Journal of the American Dietetic Association
  • 2007
More than 100 randomized controlled trials failed for the most part to demonstrate that intravenous nutrition had any effect on clinical outcome, and it is assumed that parenteral nutrition is useful in patients with an inadequate gastrointestinal tract ("short gut"). Expand
Protein consumption and hepatic encephalopathy in alcoholic hepatitis. VA Cooperative Study Group #275.
Low protein intake is associated with worsening hepatic encephalopathy while a higher protein intake correlates with improvement in hepaticEncephalopathy in patients with alcoholic hepatitis who can be treated with standard anti-encephalopathy medications. Expand